Up to one-third of all cancer cases may be prevented by healthy diets and exercise, notes FANSA

CHICAGO -- Healthy diets and exercise may prevent as many cases of cancer in the United States as not smoking, according to a recent statement by the Food and Nutrition Science Alliance (FANSA). Cancer kills more than 500,000 Americans every year. In a review of cancer research, FANSA found overwhelmingly conclusive evidence that the risk of several types of cancer can be dramatically lowered through healthy dietary practices and exercise.

"In terms of cancer prevention, a healthy diet and exercise are as important as not smoking," says Dennis Savaiano, Ph.D., chair of FANSA and Professor of Foods and Nutrition at Purdue University. "Approximately one-third of cancer cases are attributed to smoking, one-third to poor diet and lack of exercise, and one-third to genetic or other factors. Most Americans are already aware of the detrimental effects of smoking, but poor diet is cause for alarm. We need to initiate changes in behavior now, in order to reduce the number of cancer-related deaths in the years to come."

The FANSA Statement, "Diet and Cancer Prevention in the United States," specifically urges Americans to take the following steps to reduce their cancer risk:

  • Eat plenty of fruits, vegetables, whole grains, and legumes in accordance with the USDA Food Guide Pyramid.
  • Avoid high calorie foods with little nutritional value.
  • Choose activities that involve moderate or vigorous exercise.
  • Limit or abstain from alcohol intake.

The FANSA statement, which can be viewed at www.faseb.org/ascn/fansa12-99.htm, is the first step in a nationwide call for action. In order to effect a change, all food, nutrition, fitness, health, and government organizations must strive to create consumer demand for a healthy lifestyle.


Contact: Dennis Savaiano
Institute of Food Technologists

Page: 1

Related biology news :

1. Americans still consume one-third of calories from low-nutrient tip of the pyramid
2. Leader in cancer treatment and prevention research honored
3. International study findings link acne-like rash to effectiveness of new targeted cancer treatment
4. Chemical derived from vitamin-E shows early promise as cancer drug
5. New molecular link key to cellular proteins involved in cancer progression, other diseases
6. Phase II trials of second-generation antisense cancer drug planned following successful early study
7. Trial shows which brain cancer patients benefit from temozolomide
8. Genetic differences might help distinguish thyroid cancers
9. Evidence builds for potential new cancer drug target
10. New sequence involved in DNA replication timing may aid in cancer detection
11. Enzyme maintaining chromosome ends is linked to bone cancer recurrence, decreased survival

Post Your Comments:

(Date:9/28/2015)... 28, 2015 Synaptics Inc. (NASDAQ: SYNA ... announced that Lenovo has selected Synaptics , Natural ... its latest smartphone, the Vibe P1. The new ... the device and provide swift access to applications and ... Natural ID FS4202 sensor solution utilizes AES256-bit encryption of ...
(Date:9/24/2015)...  EyeLock LLC, a market leader of iris-based identity ... latest technology in Booth #602 at next week,s ASIS ... EyeLock,s iris authentication technology provides an unprecedented level ... it the most proven way to authenticate one,s identity ... deliver a fast and friendly user experience to identify ...
(Date:9/10/2015)... 2015 This report provides detailed descriptions of ... and emerging sensor types that will dominate in the ... of the wearable technology hype curve in the last ... common feature with all of them is the prominence ... most useful functions. Sensors collect data about the physical ...
Breaking Biology News(10 mins):
(Date:10/13/2015)... the United States , ... represents about 14% of all new cases of kidney cancer.   ... Canada and Europe .  PRCC represents ... --> Hutchison China MediTech Limited ("Chi-Med") (AIM: HCM) today announces ... AB (publ) ("AstraZeneca") have completed enrolment in a global Phase II ...
(Date:10/12/2015)... 2015  MiMedx Group, Inc. (NASDAQ: MDXG ), ... and patent-protected processes to develop and market advanced products ... Sports Medicine, Ophthalmic, and the Dental sectors of healthcare, ... filed against the Company has been dismissed by the ... and CEO, stated, "As we suspected, this case was ...
(Date:10/12/2015)... 12, 2015 cell surface marker detection ... 2022, according to a new report by Grand View Research, ... in incidence of oncology diseases and other cell-associated disorders. ... to reach USD 6.49 billion by 2022, according to a ... demand can be attributed to rise in incidence of oncology ...
(Date:10/12/2015)... DIEGO , Oct. 12, 2015  Patara ... debilitating allergic and inflammatory diseases and conditions, today ... A preferred stock financing. Concurrent with the close ... entered into a Loan and Security Agreement with ... up to $7 million. Patara will use the ...
Breaking Biology Technology:
Cached News: